GH Research plc (GHRS) at a glance

GH Research plc (GHRS) is a small-cap Healthcare company. It trades at $27.95, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (74/100) and its weakest is Income (40/100). It carries above-market volatility, so expect larger swings.

Price

$27.95

Market cap

$1.45B

P/E ratio

n/a

Dividend yield

None

Beta

1.31

52-week range

$11.83 to $31.44